Difference between revisions of "Team:Paris Bettencourt/Sustainability/Acceptance"
Line 23: | Line 23: | ||
We exchanged with lawmakers and food safety authorities to get their views on our project and tune it accordingly. | We exchanged with lawmakers and food safety authorities to get their views on our project and tune it accordingly. | ||
− | <p>Contact person: Dr. A. K. Sharma, on the behalf of the Chairperson and CEO of Food Safety and Standard Authority in India (FSSAI).</p> | + | <p><b>Contact person:</b> Dr. A. K. Sharma, on the behalf of the Chairperson and CEO of Food Safety and Standard Authority in India (FSSAI).</p> |
− | Advice: Choose the right microorganisms so they can survive and work togethe, along with the use of critical genes for the vitamins pathways. Concerning the law, he said that there is currently no authorisation for GMO microorganisms in the Indian Food regulation and if we want to have our product in India, the safety needs to be established. | + | <b>Advice:</b> Choose the right microorganisms so they can survive and work togethe, along with the use of critical genes for the vitamins pathways. Concerning the law, he said that there is currently no authorisation for GMO microorganisms in the Indian Food regulation and if we want to have our product in India, the safety needs to be established. |
− | <p>Contact person: Dr. Sunita Grover, principal scientist and head of the Dairy Microbiology Division at the National Dairy Research Institute</></p> | + | <p><b>Contact person:</b> Dr. Sunita Grover, principal scientist and head of the Dairy Microbiology Division at the National Dairy Research Institute</></p> |
− | Advice: Use food grade vector system to make sure our product is safe for consumption and to reduce issues arising form the | + | <b>Advice:</b> Use food grade vector system to make sure our product is safe for consumption and to reduce issues arising form the |
use of genetically modified bacteria. She had concerns about the compatibility of the different species | use of genetically modified bacteria. She had concerns about the compatibility of the different species | ||
living in fermentation batter. To finish, her major | living in fermentation batter. To finish, her major | ||
Line 36: | Line 36: | ||
<div class="column-right"> | <div class="column-right"> | ||
− | <p>Contact person: Prof. Samir K. Brahmachari, former director of India's main research body - The Council of Scientific and Industrial Research (CSIR); Chief mentor, Open Source Drug Discovery center.</p> | + | <p><b>Contact person:</b> Prof. Samir K. Brahmachari, former director of India's main research body - The Council of Scientific and Industrial Research (CSIR); Chief mentor, Open Source Drug Discovery center.</p> |
− | Advice: Regarding the law, there is no GM microorganisms that are allowed because of the use of antibiotic markers that makes them unsafe to eat. But for him if we can add a safe vitamin pathway on already eaten bacteria (lactic bacteria for example) that will be sterilized but producing enough vitamin to fortify the food, it should be possible. It is not impossible that regulatory issues can undergo changes. Concerning the GMO debate in Europe and India, the main points are different: in India, people don't want GMO to be associated with farmers, they don't want them to be dependent and no one want a monopoly of a particular plant. These issues don't apply to our project for Samir Brahmachari, but labeling would be an problem: the use of our product only depends on people's wish. If people find it beneficial and safe, they would take it. To continue, an accelerated evolution can be more acceptable for a project like ours for the GMO regulation. Also, since our project doesn't imply a big company producing and giving a product, it is more likely to work and be more accepted, as well as the way we want to implement it (give power to people, let them have their own "mini-lab" and produce their bacteria and yeast for their consumption) according to him. | + | <b>Advice:</b> Regarding the law, there is no GM microorganisms that are allowed because of the use of antibiotic markers that makes them unsafe to eat. But for him if we can add a safe vitamin pathway on already eaten bacteria (lactic bacteria for example) that will be sterilized but producing enough vitamin to fortify the food, it should be possible. It is not impossible that regulatory issues can undergo changes. Concerning the GMO debate in Europe and India, the main points are different: in India, people don't want GMO to be associated with farmers, they don't want them to be dependent and no one want a monopoly of a particular plant. These issues don't apply to our project for Samir Brahmachari, but labeling would be an problem: the use of our product only depends on people's wish. If people find it beneficial and safe, they would take it. To continue, an accelerated evolution can be more acceptable for a project like ours for the GMO regulation. Also, since our project doesn't imply a big company producing and giving a product, it is more likely to work and be more accepted, as well as the way we want to implement it (give power to people, let them have their own "mini-lab" and produce their bacteria and yeast for their consumption) according to him. |
Prof. Brahmachari visited us this summer and participated to our first workshop. We went to meet him again at the 2nd Annual Open Source Pharma Conference in Frankfurt, Germany at the end of the summer. | Prof. Brahmachari visited us this summer and participated to our first workshop. We went to meet him again at the 2nd Annual Open Source Pharma Conference in Frankfurt, Germany at the end of the summer. |
Revision as of 09:37, 27 October 2015